News

Check out this video to learn more about the latest in advanced lung failure and transplantation topics that were discussed at ISHLT2026 in Toronto this April.

A new community on ISHLTconnect is now open to all involved in the management and treatment of advanced heart and lung disease. The ISHLT Pediatric Pulmonology Special Interest Group is open to all with a special interest in pediatric pulmonology.

Watch this video to learn more about the latest in advanced heart failure and transplantation topics that were discussed at ISHLT2026 in Toronto this April.

The JHLT will release a special issue in Q4 2026 dedicated to manuscripts exploring aspects of donor selection and organ preservation related to thoracic transplantation. Submissions for this issue are now being accepted until 5:00 p.m. ET on Wednesday, 15 July, 2026.

ISHLT is currently accepting applications from ISHLT members who are interested in serving as Grant Reviewers.

Heart transplant recipient and patient advocate Payton Herres joins the podcast for a discussion about her recent perspective piece in JHLT on the problems of 'ghost approval' and the difference between health insurance coverage and access to care.

At their industry symposium at ISHLT2026, Natera highlighted how donor-derived cell-free DNA (dd-cfDNA) not only rules out rejection with high confidence, but also detects broader allograft injury. Experts discussed emerging data on EMI, which is strongly linked to poor outcomes, including increased risk of CLAD.

The ISHLT Strategic Investment Fund is now accepting proposals from ISHLT members. The Fund is designed to identify and launch ISHLT-led initiatives that advance the field of advanced heart and lung disease therapies, deliver meaningful value to members worldwide, and strengthen the Society’s leadership, programs, and long-term impact. Proposals are due by Tuesday, 18 August.

A new ISHLT Document, ISHLT Scientific Statement on Pulmonary Antibody-Mediated Rejection and Proposed Graft, Antibody, and Pathology (GAP) Definition, has been published in JHLT and is available to read online!

With the U.S. OPTN public comment period for the newly implemented Lung Composite Allocation Score (CAS) policy open through July 3, the ISHLT Advanced Lung Failure and Transplant (ALFTX) Interdisciplinary Network is convening an expert webinar to help the transplant community understand what's changing, and what's at stake.

The ISHLT and the Heart Failure Society of America (HFSA) have launched a free, five-part on-demand seminar series designed specifically for nursing and allied health professionals in advanced heart and lung transplant care. Available now.

The 2026 ISHLT Lifetime Achievement Award Lecture from 2026 recipient, John Dark, MB, FRCS is now available online.

On JHLT: The Podcast, Ufuk Baldan and Patrick Klein from the Amsterdam University Medical Center join us to discuss SCAI shock classification in patients post-cardiotomy.

Submissions are now being accepted for ISHLT2027 Symposium Proposals. ISHLT members are welcome to submit 75-minute symposia proposals to the ISHLT 47th Annual Meeting & Scientific Sessions, to be held 14-17 April, 2027 in Sydney, NSW Australia.

ISHLT is now accepting applications for three industry-supported research grants funded through the ISHLT Foundation and the International Visiting Scholarship. Apply by Wednesday, 30 September at 11:59 p.m. ET/ Thursday, 1 October at 03:59 UTC.

As the ISHLT prepares for another exciting year of groundbreaking symposia, ISHLT members can play a pivotal role in evaluating the quality and diversity of the ISHLT2027 program. Apply to serve as an ISHLT2027 Symposium Proposal Reviewer by Monday, 8 June.

The May 2026 Journal Watch highlights early career and trainee contributions to recent research across advanced heart and lung failure and transplantation.

The ISHLT Strategic Investment Fund is a targeted investment program providing up to $250,000 USD to support high-impact ideas from the Society’s global community. On 15 June, the ISHLT Strategic Investment Fund will begin accepting proposals for bold-Society-led initiatives.

On this special episode of JHLT: The Podcast, the Digital Media Editors take a look back at the exciting science that was on display at ISHLT2026, the ISHLT 46th Annual Meeting & Scientific Sessions.

At their industry symposium at ISHLT2026, Natera explored how emerging molecular tools are reshaping heart transplant surveillance beyond traditional histology. Through the support of Natera, this session is now available for you to view on demand.